The Swiss government has said it will participate in a United States-led programme to provide vaccines against the A/H1N1 virus to developing countries.
This content was published on
1 minute
On Friday, the Federal Health Office announced it had purchased 13 million doses against the virus, commonly known as swine flu, from drug makers Novartis and GlaxoSmithKline.
The vaccine sharing plan, initiated by the United States, will make at least ten per cent of doses available to the World Health Organization (WHO) for poor countries.
“Developing countries should be supplied with vaccines in parallel with industrialised countries,” the Health Office said in a statement.
Switzerland has pledged $4.8 million (SFr5 million) to procure the vaccines and is in negotiations with producers, it said.
Australia, Brazil, France, Italy, New Zealand, Norway, and Britain are also participating in the programme.
The WHO said on Friday that vaccine production would be “substantially less” than the 4.9 billion doses previously forecast. Weekly production will be less than 94 million doses, a WHO spokesman said.
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
India tightens its grip on Tamiflu
This content was published on
Tamiflu is one of two antiviral drugs said to be effective in treating the A/H1N1 flu virus that has reached pandemic levels worldwide. In one doctor’s office in Mumbai, the capsules are so precious they are kept locked in a safe. Doctor Charulata Jakhia has the key on her at all times. “It’s safest: if…
This content was published on
Switzerland, which has 20 confirmed cases, responded by saying it would not be introducing new measures to limit the spread of the disease as a result of the pandemic upgrade, but would follow the situation closely. WHO Director-General Margaret Chan told a news conference on Thursday that the scientific conditions for an influenza pandemic had…
This content was published on
The drug, developed by Swiss pharmaceutical firm Roche, would be one of the primary defences against a pandemic. Experts are closely watching the deadly flu outbreak that started in Mexico. The new strain of influenza, H1N1, is already believed to have claimed more than 150 lives in Mexico, and cases have also been detected in…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.